Nalador, liofilizzato

7680436420011 CH-43642 liofilizzato
Nalador, liofilizzato
Nalador, liofilizzato
Nalador, liofilizzato
1 / 3
google

Article details

Package size
3
Selling units
3
Measure
Durchstechflasche(n)
Galenic form
liofilizzato
Galenic group
Unknown

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
16/06/2023
Summary of Product Characteristics
Français
16/06/2023
Summary of Product Characteristics
Italien
16/06/2023

Detailed composition

Substance Quantity Type Category
PRC
0.5 MG Substance Wirkstoff (Principe actif)
PRC
- Substance HNIDK
PRC
- Substance HNIDK

Authorization holder

FARMACEUTICA TEOFARMA SUISSE SA

6900 Lugano

Authorization information

Swissmedic authorization number
43642
Drug name
Nalador, liofilizzato
Galenic form
PULVI
ATC Code
G02AD05
Authorization status
Z
Dispensing category
A
First authorization
16/07/1982
Authorization expiration date
31/12/9999
IT Number
09.01.1.
Domain
Human medicine
Field of application
Therapeutische Aborteinleitung, Geburtseinleitung bei intrauterinem Fruchttod, postpartale atonische Uterusblutungen

Package details

Description (FR)
NALADOR subst sèche 0.5 mg flac 3 pce
Description (DE)
NALADOR Trockensub 0.5 mg Durchstf 3 Stk
Market launch
16/07/1982
Narcotic (BTM)
No

Other package sizes (1)

NALADOR subst sèche 0.5 mg amp 3 pce
None None
GTIN: 7680436420226
Not in V1